Načítá se...
(82)Rubidium chloride positron emission tomography discrimination of recurrent intracranial malignancy from radiation necrosis
BACKGROUND: Accurate identification and discrimination of post treatment changes from recurrent disease remains a challenge for patients with intracranial malignancies despite advances in molecular and magnetic resonance imaging. We have explored the ability of readily available Rubidium-82 chloride...
Uloženo v:
| Vydáno v: | Q J Nucl Med Mol Imaging |
|---|---|
| Hlavní autoři: | , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2022
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7958885/ https://ncbi.nlm.nih.gov/pubmed/31820882 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.23736/S1824-4785.19.03173-X |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|